AbbVie Inc (NYSE:ABBV) on 06/20/2019 declared a dividend of $ 1.0700 per share payable on August 15, 2019 to shareholders of record as of July 15, 2019.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 5.5147533417% and has increased its dividends for 5 successive years.

AbbVie Inc's market cap is $ 114,733,346,520 and has a PE ratio of 21.62. The stock price closed yesterday at $ 77.61 and has a 52 week low/high of $ 73.81 and $ 100.23.

AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

For more information on AbbVie Inc click here.